Clinical Trials
Device Studies
Active Studies
PAGODA (Genentech Roche)
A Phase III, Multicenter, Randomized, Visual Assessor-masked, Active-comparator Study Of The Efficacy, Safety, And Pharmacokinetics Of The Port Delivery System With Ranibizumab In Patients With Diabetic Macular Edema.
PORTAL (Genentech Roche)
A Multicenter, Open-label Extension Study To Evaluate The Long-term Safety And Tolerability Of The Port Delivery System With Ranibizumab In Patients With Neovascular Age-related Macular Degeneration.
Completed Studies
ARCHWAY (Roche/Genentech)
A Phase 3, Multicenter, Randomized, Active-comparator Study Of The Efficacy, Safety, And Pharmacokinetics Of The Port Delivery System With Ranibizumab In Patients With Neovascular Age-related Macular Degeneration.
CLEAR (DigiSight)
A 3 Month, Phase 1 And 2 Studies On The Correlation Of Paxos Checkup Mobile App To Standard In Office Visual Assessment.
LADDER (Genentech)
A 20 Month, Phase 2, Multicenter, Randomized, Active Treatment-controlled Study Of The Efficacy And Safety Of The Ranibizumab Port Delivery System For Sustained Delivery Of Ranibizumab In Patients With Subfoveal Neovascular Age-related Macular Degeneration.
PAVILION (Roche)
A Phase III, Multicenter, Randomized Study Of The Efficacy, Safety, And Pharmacokinetics Of The Port Delivery System With Ranibizumab In Patients With Diabetic Retinopathy.
